Schrodinger, Inc. (NASDAQ:SDGR – Get Free Report) EVP Kenneth Patrick Lorton sold 1,222 shares of the business’s stock in a transaction dated Thursday, March 5th. The stock was sold at an average price of $12.90, for a total transaction of $15,763.80. Following the completion of the sale, the executive vice president owned 89,241 shares in the company, valued at $1,151,208.90. This represents a 1.35% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Kenneth Patrick Lorton also recently made the following trade(s):
- On Tuesday, February 10th, Kenneth Patrick Lorton sold 925 shares of Schrodinger stock. The shares were sold at an average price of $13.73, for a total transaction of $12,700.25.
Schrodinger Price Performance
SDGR traded down $0.29 during midday trading on Friday, reaching $12.74. 976,433 shares of the company’s stock were exchanged, compared to its average volume of 1,475,655. Schrodinger, Inc. has a 1-year low of $11.11 and a 1-year high of $27.63. The stock has a market capitalization of $938.56 million, a PE ratio of -8.97 and a beta of 1.57. The business’s 50-day moving average price is $14.88 and its 200 day moving average price is $17.65.
Trending Headlines about Schrodinger
Here are the key news stories impacting Schrodinger this week:
- Positive Sentiment: Yahoo Finance piece highlights an evolving investment thesis as Schrödinger shifts toward hosted software and resets targets, which could support longer-term sentiment if adoption and ARR trajectory improve. How The Schrödinger (SDGR) Investment Story Is Evolving With Hosted Software And Reset Targets
- Neutral Sentiment: Transcript from Schrödinger’s TD Cowen conference presentation provides management commentary and detail that investors can use to re-assess guidance, product roadmap and commercialization progress; useful but not an immediate catalyst. Schrödinger, Inc. (SDGR) Presents at TD Cowen 46th Annual Health Care Conference Transcript
- Negative Sentiment: CEO Ramy Farid sold 3,661 shares at an average $12.91 (≈1.09% reduction in his stake), a high-profile insider sale that can signal near-term selling pressure. CEO Form 4
- Negative Sentiment: CFO Rachit Jain sold 1,631 shares at ~$12.90 (≈3.01% reduction), adding to the cluster of exec sales that market participants often interpret as a negative signal. CFO Form 4
- Negative Sentiment: Other senior leaders (EVPs Kenneth Lorton and Yvonne Tran, CAO Jenny Herman, and insiders Robert Abel, Karen Akinsanya) executed small-to-moderate sales (roughly 600–1,366 shares each around $12.80–$12.91), collectively reducing insider holdings and contributing to downward pressure. Sample Insider Filing (Robert Abel)
- Negative Sentiment: Multiple filings show these sales occurred within a short window (Mar 4–6), which magnifies market reaction compared with isolated, scheduled sales; however, each sale is a small percentage of total insider stakes and could reflect diversification or option/vesting activity rather than a change in corporate outlook. SEC Filings
Hedge Funds Weigh In On Schrodinger
A number of hedge funds have recently made changes to their positions in SDGR. Amalgamated Bank boosted its position in shares of Schrodinger by 3.9% in the third quarter. Amalgamated Bank now owns 16,411 shares of the company’s stock worth $329,000 after buying an additional 623 shares during the period. Verity Asset Management Inc. boosted its stake in shares of Schrodinger by 1.2% in the fourth quarter. Verity Asset Management Inc. now owns 65,722 shares of the company’s stock valued at $1,175,000 after purchasing an additional 798 shares during the period. Bank of Montreal Can grew its holdings in Schrodinger by 5.8% during the 2nd quarter. Bank of Montreal Can now owns 15,941 shares of the company’s stock valued at $321,000 after purchasing an additional 879 shares in the last quarter. Handelsbanken Fonder AB increased its stake in Schrodinger by 6.3% during the 4th quarter. Handelsbanken Fonder AB now owns 15,200 shares of the company’s stock worth $272,000 after buying an additional 900 shares during the period. Finally, Stephens Inc. AR increased its position in shares of Schrodinger by 9.5% during the third quarter. Stephens Inc. AR now owns 10,894 shares of the company’s stock worth $219,000 after acquiring an additional 944 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.
Analyst Ratings Changes
SDGR has been the subject of a number of recent research reports. UBS Group initiated coverage on Schrodinger in a research report on Wednesday, January 7th. They set a “neutral” rating and a $18.00 price objective for the company. TD Cowen reiterated a “buy” rating on shares of Schrodinger in a report on Thursday, January 8th. Bank of America raised shares of Schrodinger from a “neutral” rating to a “buy” rating and set a $24.00 price objective on the stock in a research note on Monday, December 15th. KeyCorp decreased their target price on shares of Schrodinger from $28.00 to $25.00 and set an “overweight” rating on the stock in a research report on Thursday, January 8th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Schrodinger in a research note on Friday, January 9th. Four investment analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Schrodinger currently has a consensus rating of “Hold” and an average price target of $21.75.
View Our Latest Analysis on SDGR
About Schrodinger
Schrödinger, Inc is a life sciences and materials discovery company that specializes in the application of physics-based computational platforms to accelerate drug discovery and advanced materials design. Founded in 1990 by Professor Richard A. Friesner, Schrödinger has developed a suite of proprietary software tools—such as Maestro for molecular modeling, Glide for molecular docking and Jaguar for quantum chemistry calculations—that enable scientists to predict molecular behavior with high accuracy.
Featured Articles
- Five stocks we like better than Schrodinger
- Silver paying 20% dividend. Plus 68% share gains
- The biggest story of 2026 (free access)
- What happened in Cyprus could be coming here
- This makes me furious
- $30 stock to buy before Starlink goes public (WATCH NOW!)
Receive News & Ratings for Schrodinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrodinger and related companies with MarketBeat.com's FREE daily email newsletter.
